Crossmark

<scp>KIAA1429</scp> / <scp>VIRMA</scp> promotes breast cancer progression by <scp> m <sup>6</sup> A </scp> ‐dependent cytosolic <scp>HAS2</scp> stabilization

Crossref DOI link: https://doi.org/10.15252/embr.202255506

Published Online: 2023-09-14

Published Print: 2023-10-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Li, Na https://orcid.org/0000-0002-2852-8099
Zhu, Zhouting https://orcid.org/0000-0001-7763-486X
Deng, Yufei https://orcid.org/0009-0000-8776-0747
Tang, Rachel https://orcid.org/0000-0003-0364-6280
Hui, Hui

Kang, Yuqi

Rana, Tariq M https://orcid.org/0000-0001-9558-5766
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (AI125103)
License Information

Version of Record valid from 2023-09-14
More Information

Publication History

Received: 2022-05-29

Accepted: 2023-08-24

Published: 2023-09-14

Document is current

Any future updates will be listed below